Clinical Trial Update: Trial of Prophylactic Versus Empirical Vancomycin for the Prevention of Streptococcal Sepsis After Hematopoietic Cell Transplantation [Phase 3]

View source ↗

Summary

Phase 3 trial comparing prophylactic versus empirical vancomycin to prevent streptococcal sepsis after hematopoietic cell transplantation has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematologic Malignancies
• Streptococcal Sepsis

Drugs mentioned

• Vancomycin (vancomycin)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Streptococcal Sepsis, Hematologic Malignancies | Phase 3 | Status: COMPLETED